Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, China Resources Shuanghesiang Chinese Medicine (Hunan) Co., Ltd., a holding subsidiary of the company, received the “Drug Registration Certificate” for oxacipine tablets issued by the State Drug Administration. Oxcarbazepine tablets are suitable for the treatment of primary generalized tonic-clonic seizures and partial seizures, with or without secondary full-blown seizures in adults and children 5 years and older. Obtaining the “Drug Registration Certificate” this time is considered to have passed the consistency evaluation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.